T. Rowe Price Associates’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,116,328
| Closed | -$296M | – | 2577 |
|
|
2018
Q4 | $296M | Sell |
2,116,328
-106,509
| -5% | -$14.9M | 0.05% | 329 |
|
|
2018
Q3 | $380M | Buy |
2,222,837
+29,312
| +1% | +$5.01M | 0.06% | 333 |
|
|
2018
Q2 | $381M | Buy |
2,193,525
+224,442
| +11% | +$38.9M | 0.06% | 318 |
|
|
2018
Q1 | $227M | Buy |
1,969,083
+373,946
| +23% | +$43.1M | 0.04% | 430 |
|
|
2017
Q4 | $134M | Buy |
1,595,137
+1,026,101
| +180% | +$86.4M | 0.02% | 551 |
|
|
2017
Q3 | $52.4M | Buy |
569,036
+188,600
| +50% | +$17.4M | 0.01% | 825 |
|
|
2017
Q2 | $30.5M | Buy |
380,436
+374,089
| +5,894% | +$30M | 0.01% | 1014 |
|
|
2017
Q1 | $267K | Buy |
6,347
+10
| +0.2% | +$421 | ﹤0.01% | 2301 |
|
|
2016
Q4 | $204K | Sell |
6,337
-26,826
| -81% | -$864K | ﹤0.01% | 2380 |
|
|
2016
Q3 | $868K | Buy |
+33,163
| New | +$868K | ﹤0.01% | 1789 |
|